These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9568638)

  • 61. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells.
    Whitley BR; Palmieri D; Twerdi CD; Church FC
    Exp Cell Res; 2004 Jun; 296(2):151-62. PubMed ID: 15149846
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
    Festuccia C; Angelucci A; Gravina GL; Villanova I; Teti A; Albini A; Bologna M
    Int J Cancer; 2000 Feb; 85(3):407-15. PubMed ID: 10652434
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells.
    Antalis TM; Reeder JA
    Int J Cancer; 1995 Sep; 62(5):619-26. PubMed ID: 7665235
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: role of DNA methylation.
    Xing RH; Rabbani SA
    Int J Cancer; 1999 May; 81(3):443-50. PubMed ID: 10209960
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Starfish polysaccharides downregulate metastatic activity through the MAPK signaling pathway in MCF-7 human breast cancer cells.
    Lee KS; Shin JS; Nam KS
    Mol Biol Rep; 2013 Oct; 40(10):5959-66. PubMed ID: 24065532
    [TBL] [Abstract][Full Text] [Related]  

  • 66. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
    Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
    Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines.
    Gilles C; Polette M; Birembaut P; Brünner N; Thompson EW
    Clin Exp Metastasis; 1997 Sep; 15(5):519-26. PubMed ID: 9247254
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells.
    Park SY; Kim YH; Kim Y; Lee SJ
    J Cell Biochem; 2012 Dec; 113(12):3653-62. PubMed ID: 22740037
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity.
    Juarez J; Clayman G; Nakajima M; Tanabe KK; Saya H; Nicolson GL; Boyd D
    Int J Cancer; 1993 Aug; 55(1):10-8. PubMed ID: 7688350
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by human urinary bladder cancer cells.
    Hamasaki T; Hattori T; Kimura G; Nakazawa N
    Urol Res; 1998; 26(6):371-6. PubMed ID: 9879815
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
    Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
    Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.
    Levenson AS; Kwaan HC; Svoboda KM; Weiss IM; Sakurai S; Jordan VC
    Br J Cancer; 1998 Jul; 78(1):88-95. PubMed ID: 9662256
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Characterization of morphogenetic and invasive abilities of human mammary epithelial cells: correlation with variations of urokinase-type plasminogen activator activity and type-1 plasminogen activator inhibitor level.
    Fauquette W; Dong-Le Bourhis X; Delannoy-Courdent A; Boilly B; Desbiens X
    Biol Cell; 1997 Oct; 89(7):453-65. PubMed ID: 9561724
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Invasiveness and MMP expression in pancreatic carcinoma.
    Yang X; Staren ED; Howard JM; Iwamura T; Bartsch JE; Appert HE
    J Surg Res; 2001 Jun; 98(1):33-9. PubMed ID: 11368535
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9.
    Lin CW; Shen SC; Hou WC; Yang LY; Chen YC
    Mol Cancer Ther; 2008 May; 7(5):1195-206. PubMed ID: 18483307
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases.
    Binder C; Hagemann T; Husen B; Schulz M; Einspanier A
    Mol Hum Reprod; 2002 Sep; 8(9):789-96. PubMed ID: 12200455
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
    Knappe UJ; Hagel C; Lisboa BW; Wilczak W; Lüdecke DK; Saeger W
    Acta Neuropathol; 2003 Nov; 106(5):471-8. PubMed ID: 12904990
    [TBL] [Abstract][Full Text] [Related]  

  • 78. mRNA expression of urokinase and plasminogen activator inhibitor-1 in human crescentic glomerulonephritis.
    Lee HS; Park SY; Moon KC; Hong HK; Song CY; Hong SY
    Histopathology; 2001 Aug; 39(2):203-9. PubMed ID: 11493338
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells.
    Canning MT; Postovit LM; Clarke SH; Graham CH
    Exp Cell Res; 2001 Jul; 267(1):88-94. PubMed ID: 11412041
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of spontaneous and TGF-β-induced cell motility of primary human normal and neoplastic mammary cells in vitro using novel real-time technology.
    Mandel K; Seidl D; Rades D; Lehnert H; Gieseler F; Hass R; Ungefroren H
    PLoS One; 2013; 8(2):e56591. PubMed ID: 23457587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.